• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂蛋白(a)和颈动脉内膜中层厚度作为慢性肾脏病患者的心血管危险因素。

Lipoprotein-A and carotid intima media thickness as cardiovascular risk factors in patients of chronic kidney disease.

机构信息

Department of Medicine & Nephrology, Pt. B.D. Sharma Postgraduate Institute of Medical Sciences, Rohtak, Haryana, India.

出版信息

Ren Fail. 2010 Jul;32(6):647-52. doi: 10.3109/0886022X.2010.486097.

DOI:10.3109/0886022X.2010.486097
PMID:20540630
Abstract

Patients in all stages of chronic kidney disease (CKD) are considered in the "high-risk group" for development of cardiovascular disease (CVD). The study was undertaken in 60 adult patients of chronic renal failure. The patients were divided into three groups: Group I had subjects with CKD (stages 1 and 2); Group II had subjects with CKD (stages 3 and 4) on conservative therapy for 3 months; and Group III had subjects with CKD (stage 5) on regular hemodialysis for at least 3-4 weeks. Carotid sonography was done in all patients at the time of inclusion in the study. The patients in all the groups were then followed for 6 months and the relevant investigations were carried out, initially at the time of presentation, and then at third- and sixth-month interval. The patients were monitored for various renal parameters along with serum lipoprotein-A [Lp (A)]. The value of carotid intima media thickness (CA-IMT) was increased in group II and III as compared to group I. The calcification of carotids was higher in patients of group III. The maximum number of patients having plaques and stenosis in the carotids were seen in group III (50%), followed by group II (20%). Patients in group III had 5-10 times higher levels of Lp (A) as compared to patients in group I. The comparison of Lp (A) levels between group I and group II was also highly statistically significant.

摘要

所有慢性肾脏病(CKD)阶段的患者都被认为是心血管疾病(CVD)发展的“高危人群”。本研究纳入了 60 例慢性肾功能衰竭成年患者。患者被分为三组:I 组为 CKD(1 期和 2 期)患者;II 组为 CKD(3 期和 4 期)患者,接受保守治疗 3 个月;III 组为 CKD(5 期)患者,定期接受至少 3-4 周的常规血液透析。所有患者在纳入研究时均进行颈动脉超声检查。所有组的患者随后随访 6 个月,并进行相关检查,最初在就诊时进行,然后在第 3 个月和第 6 个月进行。监测患者的各种肾功能参数以及血清脂蛋白-A [Lp(A)]。与 I 组相比,II 组和 III 组的颈动脉内膜中层厚度(CA-IMT)增加。III 组患者的颈动脉钙化程度更高。III 组中颈动脉斑块和狭窄的患者最多(50%),其次是 II 组(20%)。III 组患者的 Lp(A)水平比 I 组患者高 5-10 倍。I 组和 II 组之间的 Lp(A)水平比较也具有统计学意义。

相似文献

1
Lipoprotein-A and carotid intima media thickness as cardiovascular risk factors in patients of chronic kidney disease.脂蛋白(a)和颈动脉内膜中层厚度作为慢性肾脏病患者的心血管危险因素。
Ren Fail. 2010 Jul;32(6):647-52. doi: 10.3109/0886022X.2010.486097.
2
Inflammation, homocysteine and carotid intima-media thickness.炎症、同型半胱氨酸与颈动脉内膜中层厚度
Rev Port Cardiol. 2008 Jan;27(1):39-48.
3
Association of carotid intima-medial thickness and indices of arterial stiffness with cardiovascular disease outcomes in CKD.慢性肾脏病患者颈动脉内膜中层厚度及动脉僵硬度指标与心血管疾病预后的关联
Am J Kidney Dis. 2007 Oct;50(4):622-30. doi: 10.1053/j.ajkd.2007.07.012.
4
Intima-media thickness is associated with inflammation and traditional cardiovascular risk factors in non-dialysis-dependent patients with chronic kidney disease.内中膜厚度与非透析依赖性慢性肾脏病患者的炎症和传统心血管危险因素相关。
Nephron Clin Pract. 2010;115(3):c189-94. doi: 10.1159/000313033. Epub 2010 Apr 23.
5
Association between global leukocyte DNA methylation, renal function, carotid intima-media thickness and plasma homocysteine in patients with stage 2-4 chronic kidney disease.2-4期慢性肾脏病患者全血白细胞DNA甲基化、肾功能、颈动脉内膜中层厚度与血浆同型半胱氨酸之间的关联
Nephrol Dial Transplant. 2008 Aug;23(8):2586-92. doi: 10.1093/ndt/gfn040. Epub 2008 Feb 20.
6
[Cardiovascular system in patients in different stages of chronic kidney disease].[慢性肾脏病不同阶段患者的心血管系统]
Pol Merkur Lekarski. 2006 Aug;21(122):125-9; discussion 130-1.
7
Association between carotid artery intima-media thickness and cardiovascular risk factors in CKD.慢性肾脏病患者颈动脉内膜中层厚度与心血管危险因素之间的关联
Am J Kidney Dis. 2005 Nov;46(5):856-62. doi: 10.1053/j.ajkd.2005.07.048.
8
Cardiac mass and function, carotid artery intima media thickness, homocysteine and lipoprotein levels in children and adolescents with growth hormone deficiency.生长激素缺乏的儿童和青少年的心脏质量与功能、颈动脉内膜中层厚度、同型半胱氨酸和脂蛋白水平
J Pediatr Endocrinol Metab. 2004 Oct;17(10):1405-13.
9
Carotid intima-media thickness in type 2 diabetes is more strongly related to serum apoprotein A-I in females.2型糖尿病女性患者的颈动脉内膜中层厚度与血清载脂蛋白A-I的相关性更强。
Wien Klin Wochenschr. 2001 Mar 15;113(5-6):194-8.
10
[Effect of antiretroviral therapy on carotid intima-media thickness in HIV-infected patients].[抗逆转录病毒疗法对HIV感染患者颈动脉内膜中层厚度的影响]
G Ital Cardiol (Rome). 2009 Sep;10(9):596-601.

引用本文的文献

1
Rethinking cardiovascular risk: The emerging role of lipoprotein(a) screening.重新审视心血管风险:脂蛋白(a)筛查的新作用。
Am J Prev Cardiol. 2025 Feb 14;21:100945. doi: 10.1016/j.ajpc.2025.100945. eCollection 2025 Mar.
2
Causal effect of lipoprotein(a) level on chronic kidney disease of European ancestry: a two-sample Mendelian randomization study.脂蛋白(a)水平对欧洲血统人群慢性肾脏病的因果效应:两样本孟德尔随机化研究。
Ren Fail. 2024 Dec;46(2):2383727. doi: 10.1080/0886022X.2024.2383727. Epub 2024 Jul 31.
3
Genetics and Pathophysiological Mechanisms of Lipoprotein(a)-Associated Cardiovascular Risk.
载脂蛋白(a)相关心血管风险的遗传学及病理生理学机制。
J Am Heart Assoc. 2024 Jun 18;13(12):e033654. doi: 10.1161/JAHA.123.033654. Epub 2024 Jun 15.
4
[Thromboelastography-based assessment of coagulation function in patients with chronic kidney disease and the risk factors of hypercoagulability].[基于血栓弹力图的慢性肾脏病患者凝血功能评估及高凝风险因素分析]
Nan Fang Yi Ke Da Xue Xue Bao. 2020 Apr 30;40(4):556-561. doi: 10.12122/j.issn.1673-4254.2020.04.17.
5
The role of lipoprotein (a) in chronic kidney disease.脂蛋白(a)在慢性肾脏病中的作用。
J Lipid Res. 2018 Apr;59(4):577-585. doi: 10.1194/jlr.R083626. Epub 2018 Jan 29.
6
Lipoprotein (a): impact by ethnicity and environmental and medical conditions.脂蛋白(a):受种族、环境及医疗状况的影响
J Lipid Res. 2016 Jul;57(7):1111-25. doi: 10.1194/jlr.R051904. Epub 2015 Dec 4.
7
Carotid atherosclerotic disease predicts cardiovascular events in hemodialysis patients: a prospective study.颈动脉粥样硬化疾病可预测血液透析患者的心血管事件:一项前瞻性研究。
PLoS One. 2015 Jun 1;10(6):e0127344. doi: 10.1371/journal.pone.0127344. eCollection 2015.
8
Relationship between lipoprotein (a) and micro/macro complications in type 2 diabetes mellitus: a forgotten target.2型糖尿病中脂蛋白(a)与微血管/大血管并发症之间的关系:一个被遗忘的靶点。
J Geriatr Cardiol. 2015 Mar;12(2):93-9. doi: 10.11909/j.issn.1671-5411.2015.02.001.
9
Utility of traditional circulating and imaging-based cardiac biomarkers in patients with predialysis CKD.传统循环及基于成像的心脏生物标志物在透析前慢性肾脏病患者中的应用价值。
Clin J Am Soc Nephrol. 2015 Mar 6;10(3):515-29. doi: 10.2215/CJN.03600414. Epub 2014 Nov 17.
10
Serum lipoprotein (a) and atherosclerotic changes in hemodialysis patients.血液透析患者的血清脂蛋白(a)与动脉粥样硬化改变
J Renal Inj Prev. 2013 Jun 1;2(2):47-50. doi: 10.12861/jrip.2013.17. eCollection 2013.